Fertility
105
16
17
55
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Research Maturity
55 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.6%
8 terminated out of 105 trials
87.3%
+0.8% vs benchmark
12%
13 trials in Phase 3/4
13%
7 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 55 completed trials
Clinical Trials (105)
Exploring and Validating Biomarkers in Menstrual Blood
Outcomes for Patients Who Preserved Their Fertility as Part of Cancer Treatment at the Center for the Study and Preservation of Eggs and Sperm: MaPreservFerti
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Fertility Impact of Microplastics - Advancing Countermeasures and Tracking
Validation of Donor Oocytes Semi-automated Vitrification
Kegg Fertility Study
New Strategies to Evaluate the Reproductive Tract Microbiome
Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Primary Ciliary Dyskinesia
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
Ablative Technique For Ovarian Preservation In Endometrioma
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Effect of Walnuts on Sperm Parameters and Male Fertility
Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis
Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health
Plan A Occlusion and Reversal System Feasibility Study
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT